Plexus Corp. (NASDAQ:PLXS – Get Free Report) CFO Patrick John Jermain sold 2,000 shares of the company’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $143.53, for a total value of $287,060.00. Following the sale, the chief financial officer owned 16,961 shares in the company, valued at approximately $2,434,412.33. The trade was a 10.55% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Patrick John Jermain also recently made the following trade(s):
- On Monday, October 27th, Patrick John Jermain sold 1,998 shares of Plexus stock. The stock was sold at an average price of $142.80, for a total value of $285,314.40.
- On Wednesday, August 27th, Patrick John Jermain sold 2,500 shares of Plexus stock. The stock was sold at an average price of $137.71, for a total value of $344,275.00.
Plexus Stock Performance
Shares of PLXS stock opened at $140.37 on Friday. The firm has a 50 day moving average of $143.19 and a 200-day moving average of $136.09. The company has a market cap of $3.79 billion, a price-to-earnings ratio of 22.42 and a beta of 0.80. The company has a quick ratio of 0.77, a current ratio of 1.58 and a debt-to-equity ratio of 0.06. Plexus Corp. has a 52 week low of $103.43 and a 52 week high of $172.89.
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of PLXS. Salomon & Ludwin LLC bought a new stake in Plexus during the third quarter worth $30,000. Huntington National Bank boosted its holdings in Plexus by 41.5% during the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after acquiring an additional 95 shares during the last quarter. Banque Transatlantique SA purchased a new position in Plexus during the 1st quarter worth $71,000. Johnson Financial Group Inc. bought a new stake in shares of Plexus in the 3rd quarter worth $72,000. Finally, CWM LLC raised its holdings in shares of Plexus by 65.7% in the second quarter. CWM LLC now owns 537 shares of the technology company’s stock valued at $73,000 after purchasing an additional 213 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on PLXS shares. Stifel Nicolaus set a $150.00 price target on Plexus in a research note on Friday, October 24th. Needham & Company LLC raised their price objective on Plexus from $158.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Plexus in a research report on Wednesday, October 8th. Williams Trading set a $165.00 target price on Plexus in a report on Monday, September 22nd. Finally, Sidoti downgraded shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price target for the company. in a research report on Friday, October 24th. Two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $159.00.
Get Our Latest Analysis on PLXS
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Articles
- Five stocks we like better than Plexus
- What does consumer price index measure?
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- What Are Dividend Achievers? An Introduction
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
